7,12-dihydroxymethylbenz(a)anthracene has been researched along with Animal Mammary Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nandhakumar, R; Niranjali Devaraj, S; Salini, K | 1 |
1 other study(ies) available for 7,12-dihydroxymethylbenz(a)anthracene and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Morin augments anticarcinogenic and antiproliferative efficacy against 7,12-dimethylbenz(a)-anthracene induced experimental mammary carcinogenesis.
Topics: Animals; Antioxidants; Benz(a)Anthracenes; Cell Proliferation; Cell Transformation, Neoplastic; Female; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Mammary Neoplasms, Animal; Neoplasms, Experimental; Oxidative Stress; Rats | 2012 |